title: Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors.
authors.affiliation: Department of Surgery, University of Chicago, IL 60637.
authors.forename: A O
authors.initials: AO
authors.lastname: Gaber
authors.forename: J R
authors.initials: JR
authors.lastname: Thistlethwaite
authors.forename: B W
authors.initials: BW
authors.lastname: Haag
authors.forename: J
authors.initials: J
authors.lastname: Stuart
authors.forename: J
authors.initials: J
authors.lastname: Mayes
authors.forename: S
authors.initials: S
authors.lastname: Fellner
authors.forename: F P
authors.initials: FP
authors.lastname: Stuart
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000276:immunology; D003524:Cyclosporins / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D007114:Immunization; D016030:Kidney Transplantation / Q000276:immunology*; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012307:Risk Factors; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D000961:Antilymphocyte Serum; D003524:Cyclosporins; D001379:Azathioprine; D011241:Prednisone